Masimo (MASI) Cash from Operations Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.83% |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 389.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 389.10% |
| Jan 3, 2026 | 123.31% |
| Sep 27, 2025 | 76.72% |
| Jun 28, 2025 | 194.98% |
| Mar 29, 2025 | 17.77% |
| Dec 28, 2024 | -19.80% |
| Mar 30, 2024 | -8.23% |
| Sep 30, 2023 | -29.52% |
| Jul 1, 2023 | -28.18% |
| Apr 1, 2023 | -78.86% |
| Dec 31, 2022 | -27.94% |
| Oct 1, 2022 | -41.00% |
| Jul 2, 2022 | -65.47% |
| Apr 2, 2022 | -18.25% |
| Jan 1, 2022 | 23.14% |
| Apr 3, 2021 | -6.28% |
| Sep 26, 2020 | 21.38% |
| Jun 27, 2020 | 61.15% |
| Mar 28, 2020 | 44.98% |
| Dec 28, 2019 | -40.36% |
| Sep 28, 2019 | 17.34% |
| Jun 29, 2019 | 15.46% |
| Mar 30, 2019 | 31.20% |
| Dec 29, 2018 | 7.86% |
| Mar 31, 2018 | 55.56% |
| Sep 30, 2017 | -6.84% |
| Jul 1, 2017 | -58.70% |
| Apr 1, 2017 | -16.91% |
| Dec 31, 2016 | 263.51% |
| Oct 1, 2016 | 25.63% |
| Jul 2, 2016 | 73.12% |
| Apr 2, 2016 | -9.18% |
| Jan 2, 2016 | 40.50% |
| Apr 4, 2015 | -6.30% |
| Sep 27, 2014 | 13.24% |
| Jun 28, 2014 | -7.76% |
| Mar 29, 2014 | 14.40% |
| Dec 28, 2013 | -39.62% |
| Mar 30, 2013 | -11.37% |
| Sep 29, 2012 | 11.56% |